Business Segment Information Level 3 (Tables)

3 Months Ended

Jun. 30, 2012

Notes To Financial Statements [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Financial information for each of our segments is presented in the following tables:



	Three Months Ended June 30,
	2012			2011
Revenues:
Healthcare	$	229,514		$	223,224
Life Sciences	60,496			52,868
Isomedix	46,056			42,003
Total reportable segments	336,066			318,095
Corporate and other	894			544
Total revenues	$	336,960		$	318,639
Operating income:
Healthcare	$	22,730		$	26,268
Life Sciences	11,854			9,459
Isomedix	15,578			12,959
Total reportable segments	50,162			48,686
Corporate and other	(1,860		)	(1,785		)
Total operating income	$	48,302		$	46,901

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details